Biomedical research company Alderley Analytical has received £300k funding from the Northern Powerhouse Investment Fund. The Macclesfield-based company, which currently employs 21 people, is expecting to create at least six jobs in the coming months. Alderley Analytical secured the six-figure boost through NPIF - FW Capital...
Sygnature Discovery, the UK's largest independent provider of integrated drug discovery resource and expertise, has appointed Dr Bill Marathias as Vice President of Business Development for the US to assist with the company’s ambitious international expansion plans. Sygnature Discovery already has a growing client base in...
BioCity, Glasgow based BDD Pharma secures license agreement with top pharma company for timed-release OralogiK™ technology BDD Pharma today announced that it has signed an agreement to license OralogiK™, its timed drug delivery technology, to Novartis Pharma AG for the development of a new product containing an undisclosed...
Accelerator programme graduate, BioCity, Glasgow based novosound has raised £1.5m in a seed investment round. The winner of last year's Converge Challenge competition, novosound will use the money to expand its team and bring its ultrasound sensors to the market. The bulk of the cash has been supplied...
The Antibody Company has received IBioIC investment to look at production of a food safety test using gold nanoparticles and antibodies. The Industrial Biotechnology Innovation Centre (IBioIC) awarded funding of £57,500 (€66k) to the microenterprise based at BioCity, Glasgow. The Antibody Company and the University of Strathclyde...
Award-winning MiAlgae considers move into products for human consumption Algae produced from the “co-products” of Scotland’s whisky industry could be used in health products for human consumption, the MediCity, Glasgow based MiAlgae has predicted. Douglas Martin - whose company MiAlgae was crowned Shell LiveWIRE Young Entrepreneur of the year...
MediCity Nottingham based Locate Therapeutics Ltd is the first firm to receive equity finance investment from the Midlands Engine Investment Fund (MEIF) MEIF is providing £400k as part of a £2million investment that will help the firm to deliver an innovative targeted drugs and...
Nottingham-based drug discovery company XenoGesis is set to move into BioCity Nottingham’s new Discovery Building, after receiving grant funding from the Government’s Regional Growth Fund and the University of Derby Invest to Grow Programme. XenoGesis will be taking 5,500 sq ft on the first floor of...
XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK. Clients from across the globe will be able to access highly experienced teams specialising in these core drug discovery disciplines. Both...
Marketing agency, V Formation has launched a series of workshops aimed at junior marketers looking to get to grips with the key elements of marketing. The series, entitled ‘Marketing – the nuts & bolts’, comprises four practical workshops that cover the key marketing fundamentals of marketing...